Connective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Department of Health Education & Promotion, Faculty of Health, Tabriz University of Medical Sciences, Tabriz, Iran.
Planta Med. 2020 May;86(7):457-469. doi: 10.1055/a-1143-8521. Epub 2020 Apr 9.
Considering the different untoward effects of the drugs prescribed for the treatment of rheumatoid arthritis (RA), there has been an increasing interest in adjuvant therapies devoid of such unfavorable reactions. Although the beneficial effects of () on RA have been established, it seems that its mechanisms of action have not still been reviewed. The present review is designed to evaluate the effects of on RA systematically. We searched these electronic databases until April 2019: PubMed, Scopus, ISI Web of Science, Cochrane Library, Embase, Ovid, ProQuest, and Google scholar. No restriction was conducted based on language or publication date. We selected all of the related clinical, animal, and studies. Review papers, abstracts in conferences, book chapters, and papers regarding the effects of combined with other herbs, as well as articles regarding the effects of on other diseases, were excluded. Each article was assessed critically for the possible risk of bias. Nineteen articles were reviewed. Animal and investigations supported the favorable effects of on clinical, inflammatory, oxidative, and immunologic parameters on RA, whereas results of limited clinical studies did not illustrate any change or improvement of inflammatory and oxidative biomarkers in RA. could control RA via multiple ways such as decreasing inflammation, inhibiting oxidative stress, and modulating the immune system. This paper provides persuasive clues to defend the efficacy of in RA and justifies the significance of subsequent clinical trials.
考虑到治疗类风湿关节炎 (RA) 的药物存在不同的不良反应,人们对无此类不良反应的辅助疗法越来越感兴趣。虽然已经证实 () 对 RA 有有益作用,但它的作用机制似乎尚未得到审查。本综述旨在系统地评估 对 RA 的影响。我们在 2019 年 4 月之前搜索了这些电子数据库:PubMed、Scopus、ISI Web of Science、Cochrane 图书馆、Embase、Ovid、ProQuest 和 Google Scholar。没有基于语言或出版日期进行限制。我们选择了所有相关的临床、动物和 研究。排除了综述论文、会议摘要、书籍章节以及关于 与其他草药联合作用的论文,以及关于 对其他疾病影响的论文。对每一篇文章进行了批判性评估,以确定其可能存在的偏倚风险。共审查了 19 篇文章。动物和 研究支持 对 RA 的临床、炎症、氧化和免疫参数有有利影响,而有限的临床研究结果并未表明 RA 的炎症和氧化生物标志物有任何变化或改善。 通过多种途径控制 RA,如减少炎症、抑制氧化应激和调节免疫系统。本文提供了有说服力的线索来支持 在 RA 中的疗效,并证明了后续临床试验的重要性。